Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sean Bickerton

Showing results (1-10 of 21) with videos related to

Pageof 3
Sort By:
Molecular Pharmaceutics|October 24, 2012
Interconnected roles of scaffold hydrophobicity, drug loading, and encapsulation stability in polymeric nanocarriersSean Bickerton, Siriporn Jiwpanich, S Thayumanavan
Current Pharmaceutical Design|December 8, 2016
Neurodegenerative Disease: A Perspective on Cell-Based Therapy in the New Era of Cell-Free Nano-TherapySu M Metcalfe, Sean Bickerton, Tarek Fahmy
Frontiers in Immunology|July 2, 2021
Strategies to Use Nanoparticles to Generate CD4 and CD8 Regulatory T Cells for the Treatment of SLE and Other Autoimmune DiseasesDavid A Horwitz, Sean Bickerton, Antonio La Cava
Biomacromolecules|March 30, 2012
Ligand-decorated nanogels: fast one-pot synthesis and cellular targetingJa-Hyoung Ryu, Sean Bickerton, Jiaming Zhuang, et al.
Journal of the American Chemical Society|August 5, 2010
Noncovalent encapsulation stabilities in supramolecular nanoassembliesSiriporn Jiwpanich, Ja-Hyoung Ryu, Sean Bickerton, et al.
Rheumatology and Immunology Research|December 5, 2022
Nanoparticle-mediated Delivery of IL-2 To T Follicular Helper Cells Protects BDF1 Mice from Lupus-like DiseaseConcetta Ferretti, David A Horwitz, Sean Bickerton, et al.
Frontiers in Immunology|June 14, 2021
Nanoparticles Engineered as Artificial Antigen-Presenting Cells Induce Human CD4<sup>+</sup> and CD8<sup>+</sup> Tregs That Are Functional in Humanized MiceSophia Giang, David A Horwitz, Sean Bickerton, et al.
Journal of the American Chemical Society|May 28, 2010
Surface-functionalizable polymer nanogels with facile hydrophobic guest encapsulation capabilitiesJa-Hyoung Ryu, Siriporn Jiwpanich, Reuben Chacko, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|November 9, 2018
Suppression of Murine Lupus by CD4+ and CD8+ Treg Cells Induced by T Cell-Targeted Nanoparticles Loaded With Interleukin-2 and Transforming Growth Factor βDavid A Horwitz, Sean Bickerton, Michael Koss, et al.
Frontiers in Immunology|August 13, 2025
CD2-targeted nanoparticles encapsulating IL-2 induce tolerogenic Tregs and TGF-β-producing NK cells that stabilize Tregs for long-term therapeutic efficacy in immune-mediated disordersDavid A Horwitz, Dongin Kim, Chang Kang, et al.
Pageof 3

Showing results (1-10 of 21) with videos related to

Sort By:
Pageof 3
Molecular Pharmaceutics|October 24, 2012
Interconnected roles of scaffold hydrophobicity, drug loading, and encapsulation stability in polymeric nanocarriersSean Bickerton, Siriporn Jiwpanich, S Thayumanavan
Current Pharmaceutical Design|December 8, 2016
Neurodegenerative Disease: A Perspective on Cell-Based Therapy in the New Era of Cell-Free Nano-TherapySu M Metcalfe, Sean Bickerton, Tarek Fahmy
Frontiers in Immunology|July 2, 2021
Strategies to Use Nanoparticles to Generate CD4 and CD8 Regulatory T Cells for the Treatment of SLE and Other Autoimmune DiseasesDavid A Horwitz, Sean Bickerton, Antonio La Cava
Biomacromolecules|March 30, 2012
Ligand-decorated nanogels: fast one-pot synthesis and cellular targetingJa-Hyoung Ryu, Sean Bickerton, Jiaming Zhuang, et al.
Journal of the American Chemical Society|August 5, 2010
Noncovalent encapsulation stabilities in supramolecular nanoassembliesSiriporn Jiwpanich, Ja-Hyoung Ryu, Sean Bickerton, et al.
Rheumatology and Immunology Research|December 5, 2022
Nanoparticle-mediated Delivery of IL-2 To T Follicular Helper Cells Protects BDF1 Mice from Lupus-like DiseaseConcetta Ferretti, David A Horwitz, Sean Bickerton, et al.
Frontiers in Immunology|June 14, 2021
Nanoparticles Engineered as Artificial Antigen-Presenting Cells Induce Human CD4<sup>+</sup> and CD8<sup>+</sup> Tregs That Are Functional in Humanized MiceSophia Giang, David A Horwitz, Sean Bickerton, et al.
Journal of the American Chemical Society|May 28, 2010
Surface-functionalizable polymer nanogels with facile hydrophobic guest encapsulation capabilitiesJa-Hyoung Ryu, Siriporn Jiwpanich, Reuben Chacko, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|November 9, 2018
Suppression of Murine Lupus by CD4+ and CD8+ Treg Cells Induced by T Cell-Targeted Nanoparticles Loaded With Interleukin-2 and Transforming Growth Factor βDavid A Horwitz, Sean Bickerton, Michael Koss, et al.
Frontiers in Immunology|August 13, 2025
CD2-targeted nanoparticles encapsulating IL-2 induce tolerogenic Tregs and TGF-β-producing NK cells that stabilize Tregs for long-term therapeutic efficacy in immune-mediated disordersDavid A Horwitz, Dongin Kim, Chang Kang, et al.
Pageof 3